Arachidonate is an antagonist of platelet activation by the endoperoxide analog U46619
- 1 April 1982
- journal article
- research article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - General Subjects
- Vol. 715 (2) , 246-249
- https://doi.org/10.1016/0304-4165(82)90365-8
Abstract
No abstract availableFunding Information
- U.S. Department of Health and Human Services
This publication has 14 references indexed in Scilit:
- Platelet malondialdehyde production and aggregation responses induced by arachidonate, prostaglandin-G2, collagen, and epinephrine in 12 patients with storage pool deficiencyBlood, 1981
- Characterization of the platelet response to exogenous arachidonic acidThrombosis Research, 1981
- Model for capping derived from inhibition of surface receptor capping by free fatty acids.Proceedings of the National Academy of Sciences, 1980
- Manipulation of platelet aggregation by prostaglandins and their fatty acid precursors: Pharmacological basis for a therapeutic approachProstaglandins, 1980
- Effects of all CIS-5, 8,11,14,17 eicosapentaenoic acid and PGH3 on platelet aggregationProstaglandins, 1979
- Inhibition of adenylate cyclase by adenosine analogues in preparations of broken and intact human platelets. Evidence for the unidirectional control of platelet function by cyclic AMPBiochemical Journal, 1978
- Interrelations of Platelet Aggregation and SecretionJournal of Clinical Investigation, 1977
- IUMI-AGGREGOMETER - NEW INSTRUMENT FOR SIMULTANEOUS MEASUREMENT OF SECRETION AND AGGREGATION BY PLATELETS1977
- Some biological effects of prostaglandin endoperoxide analogsLife Sciences, 1976
- Dihomo-γ-linolenate suppresses platelet aggregation when administered in vitro or in vivoProstaglandins, 1974